Unknown

Dataset Information

0

Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis.


ABSTRACT: Juvenile neuronal ceroid lipofuscinosis (JNCL), or Batten disease, is a neurodegenerative disease resulting from a mutation in CLN3, which presents clinically with visual deterioration, seizures, motor impairments, cognitive decline, hallucinations, loss of circadian rhythm, and premature death in the late-twenties to early-thirties. Using a Cln3 null (Cln3(-/-)) mouse, we report here several deficits in the cerebellum in the absence of Cln3, including cell loss and early onset motor deficits. Surprisingly, early onset glial activation and selective neuronal loss within the mature fastigial pathway of the deep cerebellar nuclei (DCN), a region critical for balance and coordination, are seen in many regions of the Cln3(-/-) cerebellum. Additionally, there is a loss of Purkinje cells (PC) in regions of robust Bergmann glia activation in Cln3(-/-) mice and human JNCL post-mortem cerebellum. Moreover, the Cln3(-/-) cerebellum had a mis-regulation in granule cell proliferation and maintenance of PC dendritic arborization and spine density. Overall, this study defines a novel multi-faceted, early-onset cerebellar disruption in the Cln3 null brain, including glial activation, cell loss, and aberrant cell proliferation and differentiation. These early alterations in the maturation of the cerebellum could underlie some of the motor deficits and pathological changes seen in JNCL patients.

SUBMITTER: Weimer JM 

PROVIDER: S-EPMC3673008 | biostudies-literature | 2009 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis.

Weimer Jill M JM   Benedict Jared W JW   Getty Amanda L AL   Pontikis Charlie C CC   Lim Ming J MJ   Cooper Jonathan D JD   Pearce David A DA  

Brain research 20090220


Juvenile neuronal ceroid lipofuscinosis (JNCL), or Batten disease, is a neurodegenerative disease resulting from a mutation in CLN3, which presents clinically with visual deterioration, seizures, motor impairments, cognitive decline, hallucinations, loss of circadian rhythm, and premature death in the late-twenties to early-thirties. Using a Cln3 null (Cln3(-/-)) mouse, we report here several deficits in the cerebellum in the absence of Cln3, including cell loss and early onset motor deficits. S  ...[more]

Similar Datasets

| S-EPMC4899816 | biostudies-literature
| S-EPMC5724993 | biostudies-literature
| S-EPMC6053093 | biostudies-literature
| S-EPMC5025599 | biostudies-literature
| S-EPMC7453105 | biostudies-literature
| S-EPMC6464704 | biostudies-literature
| S-EPMC4790084 | biostudies-literature
| S-EPMC2722895 | biostudies-literature
| S-EPMC3976549 | biostudies-literature
| S-EPMC7655432 | biostudies-literature